Practice
Featured experience
ExxonMobil $59.5 billion acquisition of Pioneer Natural Resources
We are advising ExxonMobil on the transaction
PSG VI $6 billion fundraise and $2 billion continuation fund
We advised PSG on the fundraise for PSG VI and a multi-asset GP-led secondary continuation fund transaction
Circle $1.05 billion IPO
We are advising Circle on its IPO, the first IPO by a stablecoin issuer
Switch data center project financing transactions
We advised the lenders on the project financings
VF $600 million sale of Dickies to Bluestar Alliance
We are advising VF on the transaction
VF $600 million sale of Dickies to Bluestar Alliance
We are advising VF on the transaction
VF $600 million sale of Dickies to Bluestar Alliance
We are advising VF on the transaction
VF $600 million sale of Dickies to Bluestar Alliance
We are advising VF on the transaction
VF $600 million sale of Dickies to Bluestar Alliance
We are advising VF on the transaction
Maze Therapeutics $150 million private placement
The PIPE included common stock and pre-funded warrants
Alnylam Pharmaceuticals $661.25 million convertible senior notes offering
The 0% convertible notes are due 2028
Alnylam Pharmaceuticals $661.25 million convertible senior notes offering
The 0% convertible notes are due 2028
Alnylam Pharmaceuticals $661.25 million convertible senior notes offering
The 0% convertible notes are due 2028
Cinda HK $7.4 billion guaranteed note program update and offering
The issuer sold RMB8.1 billion aggregate of guaranteed notes due 2028, 2029 and 2030